Financials
Income statement
Fiscal date | 2025 | 2024 | 2023 | 2022 |
---|---|---|---|---|
Total reported revenue | 21.7T | 20.4T | 16.9T | 14.6T |
Cost of revenue | 17.0T | 16.0T | 13.6T | 11.6T |
Gross profit | 4.7T | 4.4T | 3.3T | 3.0T |
Operating expense | ||||
Research & development | 1.1T | 923.6B | 880.9B | 787.1B |
Selling general and admin | 2.4T | 2.1T | 1.7T | 1.3T |
Other operating expenses | — | — | — | — |
Operating income | 1.2T | 1.4T | 780.8B | 871.2B |
Non operating interest income | ||||
Income | 191.1B | 173.7B | 73.1B | 25.6B |
Expense | 54.9B | 59.6B | 36.1B | 16.9B |
Other income expense | -30.8B | 186.8B | 79.2B | 197.5B |
Pretax income | 1.3T | 1.6T | 879.6B | 1.1T |
Tax provision | 414.6B | 459.8B | 162.3B | 309.5B |
Net income | 903.0B | 1.2T | 717.3B | 760.7B |
Basic EPS | 178.9 | 225.9 | 136.6 | 137.0 |
Diluted EPS | 178.9 | 225.9 | 136.6 | 137.0 |
Basic average shares | 4.7B | 4.9B | 732.6M | 742.8M |
Diluted average shares | 4.7B | 4.9B | 732.6M | 742.8M |
EBITDA | 2.1T | 2.4T | 1.7T | 1.7T |
Net income from continuing op. | 1.3T | 1.6T | 879.6B | 1.1T |
Minority interests | -67.2B | -75.4B | -65.9B | -53.6B |
Preferred stock dividends | — | — | — | — |